ONCAlert | 2018 ASCO Annual Meeting

Results for ABT-414 in Brain Cancer

Martin van den Bent, MD, PhD
Published Online: 10:43 PM, Thu November 17, 2016

Martin van den Bent, MD, Erasmus MC Cancer Center, discusses the results from the ABT-414 trial for patients with brain cancer. 

Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.